These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 17551266

  • 1. Carvedilol prevents and reverses hypertrophy-induced cardiac dysfunction.
    Barone FC, Willette RN, Nelson AH, Ohlstein EH, Brooks DP, Coatney RW.
    Pharmacology; 2007; 80(2-3):166-76. PubMed ID: 17551266
    [Abstract] [Full Text] [Related]

  • 2. Eprosartan reduces cardiac hypertrophy, protects heart and kidney, and prevents early mortality in severely hypertensive stroke-prone rats.
    Barone FC, Coatney RW, Chandra S, Sarkar SK, Nelson AH, Contino LC, Brooks DP, Campbell WG, Ohlstein EH, Willette RN.
    Cardiovasc Res; 2001 Jun; 50(3):525-37. PubMed ID: 11376628
    [Abstract] [Full Text] [Related]

  • 3. Carvedilol prevents severe hypertensive cardiomyopathy and remodeling.
    Barone FC, Campbell WG, Nelson AH, Feuerstein GZ.
    J Hypertens; 1998 Jun; 16(6):871-84. PubMed ID: 9663928
    [Abstract] [Full Text] [Related]

  • 4. Renoprotective effects of carvedilol in hypertensive-stroke prone rats may involve inhibition of TGF beta expression.
    Wong VY, Laping NJ, Nelson AH, Contino LC, Olson BA, Gygielko E, Campbell WG, Barone F, Brooks DP.
    Br J Pharmacol; 2001 Nov; 134(5):977-84. PubMed ID: 11682445
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in pressure-overloaded rat heart.
    Shyu KG, Liou JY, Wang BW, Fang WJ, Chang H.
    J Biomed Sci; 2005 Nov; 12(2):409-20. PubMed ID: 15942707
    [Abstract] [Full Text] [Related]

  • 8. [Effect of carvedilol on ryanodine receptor in heart failure].
    Li R, Yi QJ, Qian YR, Liu XY.
    Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):603-7. PubMed ID: 16191273
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
    Jovanovic D, Jovovic D, Mihailovic-Stanojevic N, Miloradovic Z, Naumovic R, Dimitrijevic J, Maksic N, Djukanovic L.
    Biomed Pharmacother; 2009 Sep; 63(8):571-6. PubMed ID: 19013753
    [Abstract] [Full Text] [Related]

  • 11. Chronic administration of carvedilol improves cardiac function in 6-month-old Syrian cardiomyopathic hamsters.
    Cruz N, Arocho L, Rosario L, Crespo MJ.
    Pharmacology; 2007 Sep; 80(2-3):144-50. PubMed ID: 17534124
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
    Khattar RS, Senior R, Soman P, van der Does R, Lahiri A.
    Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363
    [Abstract] [Full Text] [Related]

  • 14. [Effect of carvedilol and Radix astragali on ryanodine receptor in heart failure in mice].
    Li R, Zhang Q, Yi QJ.
    Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):433-8. PubMed ID: 21924056
    [Abstract] [Full Text] [Related]

  • 15. Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation.
    Zendaoui A, Lachance D, Roussel E, Couet J, Arsenault M.
    Circ Heart Fail; 2011 Mar; 4(2):207-13. PubMed ID: 21216836
    [Abstract] [Full Text] [Related]

  • 16. Oxidative inactivation of nitric oxide and endothelial dysfunction in stroke-prone spontaneous hypertensive rats.
    Ma XL, Gao F, Nelson AH, Lopez BL, Christopher TA, Yue TL, Barone FC.
    J Pharmacol Exp Ther; 2001 Sep; 298(3):879-85. PubMed ID: 11504780
    [Abstract] [Full Text] [Related]

  • 17. Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection.
    Feuerstein GZ, Ruffolo RR.
    Eur Heart J; 1996 Apr; 17 Suppl B():24-9. PubMed ID: 8733068
    [Abstract] [Full Text] [Related]

  • 18. Comparison of low and high doses of carvedilol on restoration of cardiac function and calcium-handling proteins in rat failing heart.
    Sun YL, Hu SJ, Wang LH, Hu Y, Zhou JY.
    Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):553-60. PubMed ID: 16026515
    [Abstract] [Full Text] [Related]

  • 19. Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction.
    Senior R, Basu S, Kinsey C, Schaeffer S, Lahiri A.
    Am Heart J; 1999 Apr; 137(4 Pt 1):646-52. PubMed ID: 10097224
    [Abstract] [Full Text] [Related]

  • 20. Effects of the novel multiple-action agent carvedilol on severe nephrosclerosis in renal ablated rats.
    Rodriguez-Perez JC, Losada A, Anabitarte A, Cabrera J, Llobet J, Palop L, Plaza C.
    J Pharmacol Exp Ther; 1997 Oct; 283(1):336-44. PubMed ID: 9336341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.